How does maturation affect clearance in pediatric patients?

• A. Clearance changes with maturation; neonates have reduced clearance; increases with age; often adjusted with allometric scaling and maturation factors.
• B. Clearance remains the same from neonates to adults.
• C. Clearance is higher in neonates than adults.
• D. Clearance is not affected by maturation, only weight.

Answer: (D)

Clearance in children is influenced by both body size and maturation of organ function. In neonates, kidney function (GFR) and hepatic drug-metabolizing enzymes are immature, so clearance is reduced. As children grow, these systems mature, and clearance increases toward adult values. Because weight alone doesn’t capture how fast these maturation processes occur, PK models use allometric scaling for size and add a maturation factor that describes how clearance changes with age (often tied to postmenstrual or postnatal age). This combination—maturation plus size scaling—best explains why clearance isn’t constant across ages and why dosing in pediatrics relies on both weight and maturation status. The idea that clearance is unaffected by maturation or that neonates have higher clearance than adults or that only weight matters does not fit the physiological reality of developing organ function.